Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 2Squamous Cell Carcinoma of Head and Neck 1Sarcoma 1Radiation Fibrosis Syndrome 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Postoperative Complications 1Neoplasms, Plasma Cell 1Myelodysplastic Syndromes 1Multiple Myeloma 1Lymphoma 1Lymphedema 1Laryngeal Neoplasms 1Hodgkin Disease 1Gliosarcoma 1Glioblastoma 1Fibrosis 1

Interventions

methyl N-acetylsibirosaminide 1Sodium Chloride 1Sildenafil Citrate 1Radiotherapy 1Prostatectomy 1Phentolamine 1Papaverine 1Oxaliplatin 1Neoprene 1Lymph Node Excision 1Hyperbaric Oxygenation 1Growth Hormone 1Dosage Forms 1Control Groups 1Capecitabine 1Bevacizumab 1Ascorbic Acid 1Alprostadil 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Postoperative Complications × Hyperbaric Oxygenation × Clear all
NCT00077090 2013-12-18

Hyperbaric Oxygen Therapy Compared With Standard Therapy in Treating Chronic Arm Lymphedema in Patients Who Have Undergone Radiation Therapy for Cancer

National Cancer Institute (NCI)

Phase 2 Unknown
63 enrolled
Breast

Radiation Fibrosis Syndrome, Breast Neoplasms, Lymphedema, Postoperative Complications

Data powered by HemOnc (CC BY 4.0) Colophon âš¡